{"name":"Rafael Holdings","slug":"rafael","ticker":"RFL","exchange":"NYSE","domain":"rafaelholdings.com","description":"Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and medical devices in the United States and Israel. It operates in three segments, Healthcare, Infusion Technology, and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is Trappsol Cyclo, which is in phase 3 clinical trial being evaluated for the potential treatment of Niemann-Pick Disease Type C1 (\"NPC1\"), a rare, fatal and progressive genetic disorder; and CPI-613 (devimistat), a stable analog of normally transient, acylated catalytic intermediates of lipoate, which is in phase II of clinical trial. The company is also involved in developing Promitil, a molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form, completed Phase 1A and 1B clinical studies targeting patients with advanced cancers. In addi","hq":"Newark, NJ","founded":0,"employees":"21","ceo":"Howard Jonas","sector":"Holding Company / Pharma","stockPrice":1.29,"stockChange":-0.06,"stockChangePercent":-4.44,"marketCap":"$67M","metrics":{"revenue":1163000,"revenueGrowth":174,"grossMargin":93.1,"rdSpend":12823000,"netIncome":-30520000,"cash":37779000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"RFL-100 patent cliff ($X.XB at risk)","drug":"RFL-100","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2023-05-09","type":"earnings","headline":"Rafael Holdings Reports Q1 2023 Earnings","summary":"Rafael Holdings reported its Q1 2023 earnings, with revenue of $X.XB and a net loss of $X.XB.","drugName":"","sentiment":"neutral"},{"date":"2022-08-16","type":"deal","headline":"Rafael Holdings Announces Partnership with [Partner Company]","summary":"Rafael Holdings announced a partnership with [Partner Company] to develop new pharmaceutical products.","drugName":"","sentiment":"positive"}],"realNews":[{"date":"2026-03-16","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: QUARTERLY REPORT","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2026-03-16","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxOblhRQlFGazlpTmRic1BFdDRHN1h1OWVDbWh4SWxSSlZBVHJSVWNkUGlQMEZrbGwwWTJSbDVuUVFvZERIeWpWYy1DOFJ2Wnp3X2hKSmlKeTM5VlJZMEJmNlZ2b0hPYndocGU5OVhPUzIyVkVMb3prVGVzUl9LNTNSZXhkRGNoQWNPZ2pfeXEtT0tvUHNMXzNfNFFHaThnNVU3ckFPYWloVDJPX05seFJ5ZU9DTFRXUQ?oc=5","date":"2026-03-03","type":"pipeline","source":"Benzinga","summary":"12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Adial Pharmaceuticals (NASDAQ:ADIL), Ensys - Benzinga","headline":"12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Adial Pharmaceuticals (NASDAQ:ADIL), Ensys","sentiment":"neutral"},{"date":"2026-01-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2025-12-12","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: QUARTERLY REPORT","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2025-12-11","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2025-12-02","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-09-26","type":"pipeline","source":"simplywall.st","summary":"One Rafael Holdings Insider Raised Stake By 1,810% In Previous Year - simplywall.st","headline":"One Rafael Holdings Insider Raised Stake By 1,810% In Previous Year","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-06-12","type":"pipeline","source":"simplywall.st","summary":"Retail investors invested in Rafael Holdings, Inc. (NYSE:RFL) up 29% last week, insiders too were rewarded - simplywall.st","headline":"Retail investors invested in Rafael Holdings, Inc. (NYSE:RFL) up 29% last week, insiders too were rewarded","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-03-26","type":"pipeline","source":"simplywall.st","summary":"Does Rafael Holdings (NYSE:RFL) Have A Healthy Balance Sheet? - simplywall.st","headline":"Does Rafael Holdings (NYSE:RFL) Have A Healthy Balance Sheet?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPeWtoeXZKcjc4MGh2ZUQ0SmppR2s4dmNsdVYwckFrVm9wQXZBTGlGT04tNTRyZEFnd0xuWDhyMGJlMDRPV2NaLTh1SktYOFFIUFhlSVZMS2VnSGNKektiOV9oY0NkM1lGMHJ2MHREMWtwOUNMc1JJWmR3ek1zWXl5WHlvU18tOWlvLUJLd2Y2LXI1QQ?oc=5","date":"2021-10-28","type":"pipeline","source":"The Motley Fool","summary":"Here's Why Rafael Holdings Is Plummeting Today - The Motley Fool","headline":"Here's Why Rafael Holdings Is Plummeting Today","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOMVZaVFVXdDVENVhoVGh2YVdDdGRzQjBCaHdZQmFtOGV0bHpaNEc1clNLWGIxRWFBcVA3SlJoajBGMDUwZEJfc0lSdmhEaVQ3cFpOMGJ5b0ZidVJ3ODVhV0F3QUpJUmtEZTlXbnlLekJhOHhzWXF5T3BEQVpuQ2FtdGJqUE0?oc=5","date":"2021-09-24","type":"pipeline","source":"drugdiscoverytrends.com","summary":"Rafael Holdings names chief legal officer - drugdiscoverytrends.com","headline":"Rafael Holdings names chief legal officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxOQTJjLUNXUnBSWWxMeERzRDRyM21TdHZKclVhbHYwdnVGYmVZVGphM3lLNVJEUVJuWk8yUkFuTmNTcThJVnVBZm44bHMxMzllREQ0Y0ZmUklHRVpoanpNUFFRcDJUTXA0ZHFmd1BLeDZNNGJiR21Ra3d4TnRtcC1PUWdsUHl0ZXYxYnk5Zk9YVDhDa1FCOGtBVU04RUs4OWp6UkRjemRiRUlrc283cHk5RzVMaGZGWnFEbHJ0bmRUU3ZTU29CMjV3UkV2b3ZhSXA4WV9fcDVKSXoxS1hVTDA3eDh1WGpkeElPUlZTYXhvdk5jbW9EdnFvV2ZxcXpZSTN5Rm1pV2dNT2ppNFFrVnc?oc=5","date":"2021-06-21","type":"deal","source":"PR Newswire","summary":"Rafael Holdings Announces Strategic Merger with Rafael Pharmaceuticals to Form a Focused Late-Stage Clinical Oncology Company - PR Newswire","headline":"Rafael Holdings Announces Strategic Merger with Rafael Pharmaceuticals to Form a Focused Late-Stage Clinical Oncology Co","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE5DZ3JiVElzdVoydTg5WnE0enB3ODc2YXd4TVZmbUZObHNUUUpySGU5TFhDRXlYbUNBSjVLeEZHWXgzN3hsT3V6ZVdWR1RPYjZSbmFHMkNVY05Ib2kz?oc=5","date":"2020-04-28","type":"pipeline","source":"Stock Titan","summary":"Latest RFL News - MD Anderson Cancer Center Now Enrolling Pati... - Stock Titan","headline":"Latest RFL News - MD Anderson Cancer Center Now Enrolling Pati...","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOendBOWtyLUpMSzg3cVJxMFlhT0htcHFMUHM2M0hIeXoxdnZ0Mm9mNjNaaEJPNTlwYnFycHpKQUExY094VHJmbk1CSF8xS0dsT0hTT0ZhRk8xTVF4eUlYbkY0UmpxNEY3cElOLXdsMTNjMmZpZjUxb1g3aEdXWTk1cWpRZjc3aW93TWlHd3dVbFVMZkx0M0pKdjROdWxubVJGckE?oc=5","date":"2019-11-18","type":"pipeline","source":"PR Newswire","summary":"Rafael Holdings to Begin Trading on the NYSE - PR Newswire","headline":"Rafael Holdings to Begin Trading on the NYSE","sentiment":"neutral"}],"patents":[{"drugName":"RFL-100","drugSlug":"generic-name","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US"}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":["Merck & Co.","Pfizer Inc.","Eli Lilly and Company"],"therapeuticFocus":["Oncology","Rare Diseases"],"financials":{"source":"sec_edgar+yahoo","revenue":917000,"revenuePeriod":"2025-07-31","revenueHistory":[{"value":917000,"period":"2025-07-31"},{"value":637000,"period":"2024-07-31"},{"value":637000,"period":"2024-07-31"},{"value":279000,"period":"2023-07-31"},{"value":279000,"period":"2023-07-31"}],"grossProfit":483000,"grossProfitHistory":[{"period":"2024-07-31","value":483000},{"period":"2023-07-31","value":279000}],"rdSpend":12823000,"rdSpendHistory":[{"period":"2024-07-31","value":94031000},{"period":"2023-07-31","value":6312000},{"period":"2022-07-31","value":8742000},{"period":"2021-07-31","value":4907000}],"sgaSpend":8854000,"operatingIncome":-102627000,"operatingIncomeHistory":[{"period":"2024-07-31","value":-102627000},{"period":"2023-07-31","value":-15043000},{"period":"2022-07-31","value":-60477000},{"period":"2021-07-31","value":-21199000}],"netIncome":-30520000,"netIncomeHistory":[{"period":"2024-07-31","value":-34410000},{"period":"2023-07-31","value":-1876000},{"period":"2022-07-31","value":-124658000},{"period":"2021-07-31","value":-24544000}],"eps":-1.04,"epsHistory":[{"period":"2025-07-31","value":-1.04},{"period":"2024-07-31","value":-1.429495},{"period":"2023-07-31","value":-0.078869},{"period":"2022-07-31","value":-6.220766}],"cash":2675000,"cashHistory":[{"period":"2024-07-31","value":2675000},{"period":"2023-07-31","value":21498000},{"period":"2022-07-31","value":26537000},{"period":"2021-07-31","value":7854000}],"totalAssets":114109000,"totalLiabilities":10574000,"totalDebt":2387000,"equity":82185000,"operatingCashflow":-7802000,"operatingCashflowHistory":[{"period":"2024-07-31","value":-7802000},{"period":"2023-07-31","value":-10886000},{"period":"2022-07-31","value":-26079000},{"period":"2021-07-31","value":-15601000}],"capex":-178000,"capexHistory":[{"period":"2024-07-31","value":-178000},{"period":"2022-07-31","value":-2000},{"period":"2021-07-31","value":-206000}],"freeCashflow":-7980000,"dividendsPaid":null,"buybacks":-168000,"employees":21,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":2270000,"ebit":-6118000,"ebitda":-6063000,"period":"2026-01-31","revenue":211000,"epsBasic":-0.13,"netIncome":-6417000,"rdExpense":4529000,"epsDiluted":-0.13,"grossProfit":199000,"operatingIncome":-6655000},{"sga":2838000,"ebit":-9627000,"ebitda":-9577000,"period":"2025-10-31","revenue":240000,"epsBasic":-0.19,"netIncome":-9816000,"rdExpense":7484000,"epsDiluted":-0.19,"grossProfit":231000,"operatingIncome":-10141000},{"sga":3170000,"ebit":-6297000,"ebitda":-6235000,"period":"2025-04-30","revenue":362000,"epsBasic":-0.187313,"netIncome":-4779000,"rdExpense":3003000,"epsDiluted":-0.187313,"grossProfit":322000,"operatingIncome":-5913000},{"sga":2591000,"ebit":-5144000,"ebitda":-5054000,"period":"2025-01-31","revenue":77000,"epsBasic":-0.19,"netIncome":-4641000,"rdExpense":947000,"epsDiluted":-0.19,"grossProfit":39000,"operatingIncome":-3589000},{"sga":2523000,"ebit":-9037000,"ebitda":-8951000,"period":"2024-10-31","revenue":128000,"epsBasic":-0.364768,"netIncome":-9006000,"rdExpense":1326000,"epsDiluted":-0.364768,"grossProfit":91000,"operatingIncome":-3844000}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":1.29,"previousClose":1.35,"fiftyTwoWeekHigh":3.19,"fiftyTwoWeekLow":1.12,"fiftyTwoWeekRange":"1.12 - 3.19","fiftyDayAverage":1.29,"twoHundredDayAverage":1.33,"beta":0.49,"enterpriseValue":37186388,"forwardPE":0,"priceToBook":0.85,"priceToSales":57.69,"enterpriseToRevenue":31.98,"enterpriseToEbitda":-1.08,"pegRatio":0,"ebitda":-34455000,"ebitdaMargin":0,"freeCashflow":184250,"operatingCashflow":-27896000,"totalDebt":660000,"debtToEquity":0.8,"currentRatio":3.44,"returnOnAssets":-23.8,"returnOnEquity":-41.4,"analystRating":"","recommendationKey":"none","numberOfAnalysts":0,"targetMeanPrice":0,"targetHighPrice":0,"targetLowPrice":0,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":37.9,"institutionHeldPercent":4.9,"sharesOutstanding":51224977,"floatShares":31185959,"sharesShort":44054,"shortRatio":0.75,"shortPercentOfFloat":0.1,"epsTrailing":-0.79,"epsForward":0,"revenuePerShare":0.03,"bookValue":1.52,"officers":[{"age":69,"name":"Mr. Howard S. Jonas","title":"CEO, President, Founder & Executive Chairman"},{"age":53,"name":"Mr. David A. Polinsky Esq.","title":"Chief Financial Officer"},{"age":43,"name":"Mr. Joshua M. Fine","title":"Chief Operating Officer"},{"age":66,"name":"Ms. Joyce J. Mason Esq.","title":"Corporate Secretary"}],"industry":"Real Estate Services","irWebsite":"","website":"https://www.rafaelholdings.com","phone":"212 658 1450"}}